Prime Medicine logo

Prime Medicine jobs and careers

Cambridge. Jobs in Cambridge

9Open roles
5Posted in the last 7 days
$166kAverage listed base pay
$313kHighest listed base pay

About Prime Medicine

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is leveraging its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated, one-time, potentially curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Prime Medicine is currently progressing a diversified portfolio of...

Founded in 2019 by Andrew Anzalone and David R. Liu.

Founded
2019
Employees
101 to 250
Total funding
$330M
Headquarters
Cambridge
Hiring in
1 city

Leadership

The top of Prime Medicine's org chart, with how many people report into each leader.

AAPhoto of Andrew Anzalone

Andrew Anzalone

Vice President, Platform Technologies and Innovation

13 reports

ALPhoto of Ann Lee

Ann Lee

CTO

3 reports

JDPhoto of Jeremy Duffield

Jeremy Duffield

CSO

7 reports

CAPhoto of Carman Alenson

Carman Alenson

Chief Accounting Officer and SVP Finance

3 reports

MAPhoto of Mohammed Asmal

Mohammed Asmal

SVP & Head of Clinical

16 reports

CBPhoto of Chris Bell

Chris Bell

Vice President

YK

Yune Kunes

Vp, Head Of Analytical Development, Formulation And Early Stage QC

30 reports

YPPhoto of Yi Pu

Yi Pu

Group Head

APPhoto of Alexandria Petrusich

Alexandria Petrusich

Vice President Clinical Science

2 reports

JGPhoto of Jennifer Gori

Jennifer Gori

Senior Vice President

10 reports

RGPhoto of Robert Greene

Robert Greene

Senior Director, Head Of External Manufacturing

6 reports

KLPhoto of Ken Leslie

Ken Leslie

VP Business Development

5 reports

KSPhoto of Krissy Zambouras, sHRBP

Krissy Zambouras, sHRBP

Vice President, HR Business Partner And People Operations

1 report

KBPhoto of Karen Brown

Karen Brown

SVP, Intellectual Property & Legal Affairs

4 reports

ASPhoto of Amanda Soto

Amanda Soto

Employee Experience Manager

DHPhoto of David Hsiung

David Hsiung

Director, Cell Process Sciences & Engineering

2 reports

SAPhoto of Seth C. Alexander

Seth C. Alexander

Director, RNA Technologies And Protein Sciences

3 reports

MPPhoto of Mallik Putta

Mallik Putta

Senior Director, Guide RNA And Mrna Chemistry

JLPhoto of Jonathan Levy

Jonathan Levy

Principal Scientist, Platform Delivery Innovation

7 reports

NMPhoto of Norbert Milejczak

Norbert Milejczak

Director, Infrastructure & Cloud Computing

2 reports

ARPhoto of Anita R.

Anita R.

Executive Assistant to CSO

JSPhoto of Jacob Stewart-Ornstein

Jacob Stewart-Ornstein

Sr. Director, Off-target Biology And Computational Sciences

3 reports

RAPhoto of Rowshon Alam

Rowshon Alam

Vice President, Head of Chemistry (Medicinal, Process, and In-process Analytics) at Prime Medicine

STPhoto of Sarah Trusiak

Sarah Trusiak

Director, Next-Gen Sequencing and Screening

Board

MKPhoto of Michael Kelly

Michael Kelly

Board Member

KFPhoto of Kaye Foster

Kaye Foster

Board Member (nasdaq: Prime)

TCPhoto of Thomas Cahill

Thomas Cahill

Board Member

WCPhoto of Wendy Chung

Wendy Chung

Board Member

RNPhoto of Robert Nelsen

Robert Nelsen

Board Member

DSPhoto of David Schenkein

David Schenkein

Board Member